Objective: The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) has been shown to be an effective screener for detecting neurocognitive impairments in English speaking forensic psychiatric inpatients, but no studies have examined whether the RBANS would have the same utility among monolingual Spanish speaking inpatients. This study sought to examine RBANS performance, as well as risk factors (i.e., educational, neurological, and medical) influencing RBANS performance, in that particular population. Method: The present study examined archival data collected from monolingual Spanish speaking inpatients (n = 34; mean age = 48.71, SD = 11.99; 85.3% men; 93.5% with Schizophrenia Spectrum Disorder). All participants must have RBANS data, and must not have a diagnosis of malingering or major neurocognitive disorder. Medical records of eligible participants were examined. Results: Our findings indicated that most participants (75.8%) performed in the impaired range for the RBANS Total Index; however, the frequency of impaired performances varied on more specific RBANS indices (42.4%-72.7% of the participants). Although neurological and medical risk factors were not associated with RBANS Total Index performance (all p's = .26-.82), years of education appeared to be inversely associated with RBANS Total Index score (all p's = .04-.07). Conclusions: These findings can serve as the first step in helping to define "normative" cognition among Spanish speaking forensic psychiatric inpatients. Such findings can reduce the likelihood of over-pathologizing performance and increase the likelihood that treatment goals will be better tailored to the patient's cognitive ability.
Introduction
The delivery of culturally and linguistically appropriate neuropsychological services, particularly for the growing population of Spanish speaking patients, is among the biggest challenges currently facing clinical neuropsychology. The most recent U.S. Census reports that the Hispanic population has increased by 43% from 2000 to 2010, making it the largest minority group in the United States (U.S. Bureau of the Census, 2010). Within this minority group, approximately 76% are Spanish speakers at home, with approximately 47% requiring assistance with the English language. Considering the language barriers and cultural differences present in this growing population, the delivery of neuropsychological services needs to be culturally and linguistically appropriate.
While the need for Spanish speaking health care services is clear, only one comprehensive study has examined the extent of culturally competent neuropsychological services available for Hispanics. Notably, this study found that a significant number of neuropsychologists in the United States report that their professional work involves providing services to ethnic minority individuals; however, these neuropsychologists report having little or no training in working specifically with the Hispanic population (Echemendia, Harris, Congett, Diaz, & Puente, 1997) . Moreover, even when a neuropsychologist has the ability to provide services to Spanish speakers, there is a lack of instruments and/or normative data available to make proper diagnoses and treatment recommendations (Puente & Ardila, 2000) . Collectively, neuropsychological test performances of Spanish speakers can be difficult to interpret due to these aforementioned limitations. More importantly, such difficulty is further compounded when one considers that there are unique manifestations of cognitive impairments in Spanish speaking individuals. For example, Spanish speaking individuals with dementia performed lower than English speakers on tasks of functional abilities, despite there being a lack of differences between Spanish and English control groups (Lowenstein, Ardila, Rosselli, Hayden, Duara, & Berkowitz, 1992) . Furthermore, neuropsychological tests tend to overestimate the level of cognitive impairments (Mindt, Byrd, Saez, & Manly, 2010) . In sum, there is a general lack of information and resources to properly assess linguistically and culturally diverse Spanish speakers. This paucity of information is particularly true for Spanish speaking forensic psychiatric inpatients; in fact, a search of the literature concerning psychiatric inpatients who are monolingual Spanish-speakers yielded no results. In general, individuals admitted to forensic psychiatric settings have a large number of neuropsychological risk factors and are subsequently at an increased risk for neuropsychological compromises (Bailie, King, Kinney, & Nitch, 2012; Martell, 1992; Slaughter, Fann, & Edhe, 2003) . For instance, Martell (1992) reported that 64% of a sample of patients recruited from a maximum security state hospital for mentally disordered offenders had multiple indicators of neuropsychological dysfunction. Of note, such neuropsychological dysfunction has been associated with decreased functional outcomes and poorer long-term outcomes, such as longer length of stay (Green, Kern, Braff, & Mintz, 2000; Ross, Padula, Nitch, & Kinney, 2015) . In forensic psychiatric inpatient facilities, neuropsychological screening has been frequently utilized to identify patients with neuropsychological dysfunction and to subsequently aid in treatment recommendations; for instance, neuropsychological test results can help with patient management, medical treatment, educational placement, work detail, psychotherapy, and release planning (Iverson, Franzen, Damarest, & Hammond, 1993; Ross et al., 2015) .
In sum, the use of neuropsychological tests can have important implications for the identification of cognitive impairments and for effective treatment planning to improve outcomes among forensic psychiatric inpatients. Although neuropsychological testing is frequently utilized in inpatient settings, there is a general lack of information to properly assess linguistically and culturally diverse Spanish speaking forensic psychiatric inpatients. Of note, these issues are further compounded when one considers the following: (1) there may be unique manifestations of cognitive impairments in Spanish speaking individuals; and (2) neuropsychological tests tend to overestimate the level of cognitive impairments in Spanish speaking individuals (Lowenstein et al., 1992; Mindt et al., 2010) . The primary goal of this study is to examine the results of a frequently used neuropsychological test (i.e., the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)) among forensic psychiatric Spanish speaking inpatients. Results of this study can aid in: (1) developing more accurate interpretive guidelines for examining RBANS performance in this population; and (2) developing more effective treatment approaches based upon RBANS results to ensure optimal long-term outcomes for this population.
Using RBANS to Measure Cognitive Impairments
The RBANS is a test (administration time is approximately 20-30 min) that has been shown to be an effective screening tool for neurocognitive impairment among English speaking individuals (Randolph, 1998) . Previous studies have demonstrated that the RBANS is a useful screener for assessing cognitive impairments among psychiatric inpatients, including inpatients with Schizophrenia Spectrum Disorders (SSDs) (Bailie et al., 2012; Gold, Queern, Iannone, & Buchanan, 1999) . The RBANS consists of multiple indices: (1) Immediate Memory Index measures the ability to remember information immediately after it is presented; (2) Language Index measures verbal responding ability; (3) Visuospatial/Constructional Index measures the ability to perceive spatial relations and to spatially construct; (4) Attention Index measures the capacity to remember and manipulate information in short-term memory storage; and (5) Delayed Memory Index measures anterograde memory capacity. The following should be noted: (1) each of the aforementioned index is quantified using two or more subtests; and (2) overall global cognitive functioning (Total Index) can be quantified using the five aforementioned indices.
While frequently utilized among inpatients, typical RBANS performance can differ greatly between inpatients in forensic psychiatric settings as compared to inpatients in other settings. For instance, one study examined neuropsychological performance among a large cohort (n = 174) of inpatients diagnosed with Schizophrenia or Schizoaffective Disorder in a Canadian psychiatric hospital (Iverson, Brooks, & Haley, 2009) . Results of this study indicated that 57.1% of the participants performed in the impaired range on multiple aspects of cognition; specifically, they performed two standard deviations below the published normative data on two or more aspects of cognition measured by the RBANS. Moreover, a more recent study examined average cognitive performance and the affect of neuropsychological risk factors on cognitive performance in a large cohort of forensic psychiatric inpatients (n = 260) in a maximum-security state hospital in California (Bailie et al., 2012) . Results of this study indicated that: (1) 35.8% of the sample performed two standard deviations below the mean on the RBANS Index Score (measuring global cognition); (2) 65% of the sample reported a history of developmental delays, less than 12 years of education, or past learning difficulties; and (3) participants reporting a history of academic difficulties performed worse on the RBANS Total Index and were more likely to be deemed impaired on the RBANS Total Index.
Using RBANS for Spanish Speaking Forensic Inpatients
Spanish speakers make up a significant portion of individuals receiving treatment in forensic psychiatric inpatient settings, such as state hospital systems (Durbin, Rudoler, Durbin, Laporte, & Callaghan, 2014; Manderscheid, Atay, & Crider, 2009; Price, David, & Otis, 2004) . However, few studies to date have looked at how Spanish speaking individuals perform on neuropsychological measures in forensic psychiatric inpatient settings; as such, there are fewer measures of neurocognitive status in this population. Given the proven utility of the RBANS as a cognitive screener among English speaking psychiatric inpatients (Bailie et al., 2012; Gold et al., 1999) , using the RBANS as a cognitive screener among U.S. residing Spanish speaking psychiatric inpatients may also prove clinically useful.
The use of the RBANS as a cognitive screener for Spanish speaking psychiatric inpatients has recently been facilitated by the Spanish translated version of the RBANS, which was accompanied by Spanish speaking corrected norms (Randolph, 2012) . This version utilized a literal Spanish translation of the English version; however, when the literal translation did not prove to be useful, conceptually similar words were selected. Translations were then reviewed by Spanish speaking professionals to assure that the instructions and test items were accurate and culturally sensitive. Using Spanish speaking examinees that were demographically matched to English speakers, an equivalency study was done to determine whether the current RBANS normative data was appropriate for use with the Spanish version of the RBANS. Results of this equivalency study indicated a high degree of similarity between subtests for both groups, with the exception of differences in four subtests-including subtests measuring confrontational naming, auditory attention, processing speed, and line orientation. Subsequently, a correction to that increases the raw score is suggested for these four subtests. The RBANS test manual concludes that using normative data for the adjusted raw scores on the Spanish version will yield expected results for Spanish speaking residents in the United States.
A literature review revealed that four studies have examined RBANS performance among Spanish speakers (De la Torre et al., 2014; De la Torre, Perez, Ramallo, Randolph, & Gonzalez-Willegas, 2016; Encias, Gramunt-Fombuena, Guia, Hernanz, & Barbera, 2012; Sanz, Vargas, & Marin, 2009) . At the same time, although the RBANS Spanish protocol and normative information was published for use in 2012, no studies have looked at how psychiatric patients would perform on the updated RBANS (i.e., using the raw score corrections suggested in the manual). Additionally, no studies have examined how monolingual Spanish speakers in the United States perform on the RBANS. Notably, the four studies cited earlier examined the performance of the RBANS with individuals from Spain. Additionally, out of those four aforementioned studies, only two have assessed individuals with Schizophrenia (De la Torre et al., 2016; Sanz et al., 2009) .
In an earlier study based in Spain, Sanz and colleagues (2009) examined the RBANS performance among Spanishspeaking individuals between the ages of 18 and 60-including Spanish speaking patients diagnosed with Schizophrenia, Spanish-speaking inpatients diagnosed with non-psychotic disorders, and healthy community dwelling Spanish speaking participants. Using the normative data established in the original English manual (without use of the corrected norms), the authors found that: (1) approximately 70% of patients with Schizophrenia and 53% of inpatients with non-psychotic disorders had a total index score less than 75; and (2) none of the community dwelling subjects had a total index score less than 75.
In a more recent study that was also based in Spain, compared RBANS performance of 88 healthy individuals with RBANS performance of 88 individuals diagnosed with Schizophrenia on the Spanish version of the RBANS (De la Torre et al., 2016) . Using the normative data established in the original manual, they found that: (1) healthy individuals obtained higher values than did the schizophrenia group for most indices, with the exception of the visuospatial/constructional index; and (2) the RBANS had strong specificity and sensitivity, with sensitivity for a Schizophrenia diagnosis being 87.5% and specificity being 86.4%.
Collectively, results from those two aforementioned studies demonstrated that the Spanish version of the RBANS is a useful screening tool for assessing neuropsychological status for a population in Spain, with high sensitivity to cognitive impairments frequently observed in Schizophrenia and non-psychotic inpatients. At the same time, although the RBANS Spanish protocol and normative information was published for use in 2012, no studies to date have looked at how monolingual Spanish speaking psychiatric inpatients would perform on the updated RBANS (i.e., using the raw score corrections suggested in the manual).
Study Aims
For Spanish populations, the Spanish version of the RBANS was found to be a useful screening tool for assessing neuropsychological status, with high sensitivity to cognitive impairments frequently observed in Schizophrenia and non-psychotic inpatients. However, little is known about how monolingual Spanish speakers in the United States perform on the RBANS Spanish Version. Given that there are significant differences in neuropsychological performance between different Spanish speaking countries (Bure-Reyes et al., 2013) , understanding the performance of monolingual Spanish speakers in the United States is extremely important in order to use the RBANS confidently in clinical practice. Although the RBANS has proven to be a valuable cognitive screening tool with English speaking individuals from a variety of subgroups, the same still needs to be demonstrated for monolingual Spanish speakers, including monolingual Spanish speaking forensic inpatients.
The present study is an exploratory investigation of how forensic psychiatric inpatients who are monolingual Spanish speakers perform on the RBANS. This study utilized a sample of inpatients committed to a maximum-security state psychiatric hospital in the United States. Additionally, this study employed the corrected raw scores proposed by the updated RBANS Manual (Randolph, 2012) . The goals of the present study were to: (1) identify typical performance of Spanish speaking psychiatric inpatients on the RBANS; and (2) determine if any neuropsychological or demographic risk factors were useful in identifying inpatients with neuropsychological impairments on the RBANS. These findings have important implications for the guidelines used for interpreting the Spanish version of the RBANS, as well as the treatment recommendations stemming from interpreted results of the Spanish version of the RBANS.
Method

Participants
The present study examined archival data collected from inpatients at a large maximum-security state psychiatric hospital located in Southern California. Approval for this study was obtained by the State of California's Committee for the Protection of Human Subjects. All potential participants met the following inclusion criteria: (1) they were identified by their treatment team to be primarily Spanish speakers; and (2) they were administered the RBANS-Spanish Research Version during their stay at Patton State Hospital. Of the 44 forensic inpatients who met the initial inclusion criteria, nine had a diagnosis of Major Neurocognitive Disorder and one had a diagnosis of Malingering and were thus excluded. The pattern of results did not change with these exclusions. Of the participants in the final sample (final n = 34), one did not have complete RBANS data; as a result, only 33 participants had an RBANS Total score. Of the 33 participants, multiple participants were missing data from key variables. As a result of these aforementioned factors, most primary data analyses included fewer than 34 participants (n = 25-34 across key study analyses).
The average participant was 48.71 years of age (SD = 11.99 years), with age ranging from 25 to 87 (see Table 1 for participants' demographic characteristics). The average participant had been in the United States for 4.91 years (SD = 0.46) and had 5.94 years (SD = 2.98) of education. About half of the sample grew up in a rural setting (50%). All participants in the sample were ethnically Hispanic, with a majority of participants being born in Mexico (68.5%). Most participants were men (85.3%), right handed (96.9%), and endorsed a history of having unskilled occupations (38.7%). Although most participants denied having risk factors for cognitive impairments (58.8%-97.1% denied risk factors), we found that 88.2% of the sample endorsed having at least one risk factor for cognitive impairment-with 67.6% endorsing at least one educational risk factor, 38.2% endorsing at least one medical risk factor, and 54.1% endorsing at least one neurological risk factor.
All participants were involuntarily committed and were receiving psychiatric treatment (see Table 2 for a summary of commitment types and psychiatric diagnoses). Multiple commitment types were represented in the sample-including Incompetent to Stand Trial (55.9%; California Penal Code 1370), Not Guilty by Reason of Insanity (26.50%; California Penal Code 1026), Post-Parole Mentally Disordered Offender (8.80%; California Penal Code 2972), and Murphy Conservatorship (2.90%; Welfare and Institutions Code 5008). Primary Axis I diagnosis was: (1) obtained from medical records and based on the assessment of an interdisciplinary treatment team; and (2) was based on criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition, Text Revision. Most participants in the sample had a primary diagnosis of Schizophrenia or another psychotic disorder (93.5%).
Measures
As part of routine clinical assessment, each participant completed the RBANS-Spanish Research Version (Randolph, 2012) . The RBANS is a relatively rapid test (administration time approximately 20-30 min) that has been shown to be an effective screening tool for a wide range of neurocognitive abilities (Randolph, 1998) . In particular, the RBANS has been shown to be a highly useful screener for assessing cognitive impairments among patients with psychiatric conditions (Bailie et al., 2012; Baune et al., 2010; Dickerson et al., 2004; Gold et al., 1999; Hobart, Goldberg, Bartko, & Gold, 1999) .
Additionally, the RBANS has also been purported to have strong psychometric properties (McKay, Casey, Wertheimer, & Fichtenberg, 2007; Pachet, 2007; Randolph, 1998) .
The RBANS-Spanish Research Version is composed of 12 subtests and 5 age-corrected index scores (Randolph, 2012) : (1) Immediate Memory Index is measured using List Learning and Story Memory subtests; (2) Visuospatial/Constructional Index is measured using Figure Copy and Line Orientation subtests; (3) Language Index is measured using Picture Naming and Semantic Fluency subtests; (4) Attention Index is measured using Digit Span and Coding subtests; and (5) Delayed Memory Index is measured using List Recall, List Recognition, Story Recall, and Figure recall subtests. The RBANS Total score, a composite of all subtests, was calculated and selected as the primary dependent variable. Total and index scores are presented as standard scores with a mean of 100 and a standard deviation of 15. Neuropsychological functioning was categorized as "impaired" if the Total score is two standard deviations below the mean of the standardization sample (<70). In this 
Procedure
Approval for this study was obtained by the State of California's Committee for the Protection of Human Subjects. The present study examined archival data collected from inpatients at a large maximum-security state psychiatric hospital located in Southern California. Medical records of eligible participants were examined to: (1) compile demographic characteristics; (2) collect clinical information, including DSM-IV-TR diagnoses; and (3) investigate the presence of risk factors, which were identified a priori. Presence of a risk factor was dichotomized as either "yes" or "no", with a positive endorsement indicating that the risk factor is present. Multiple psychiatric diagnoses, participant characteristics, and risk factors (i.e., educational, medical, and neurological) were present in the medical records (see Tables 1-3) .
Data Analyses
To examine RBANS performances of our sample, RBANS Total score and Index scores were analyzed using descriptive and frequency analyses. Using independent samples t-test, correlational analyses, and one-way analyses of variance, we examined whether RBANS Total score would differ across participant characteristics. Independent samples t-tests, as well as correlational analyses, were used to examine whether number of risk factors and specific risk factors would influence performance on the RBANS Total Index score. Risk factors included educational, neurological, medical, and combined risk factors (see Table 3 ).
Results
Preliminary Analyses
The average RBANS Total Index score was 61.64 (SD = 11.96), with total scores ranging from 44 to 95 (see Table 4 ). Frequency distribution revealed that 75.80% of the sample had a Total Index score that was in the impaired range (Total Index score <70), but that only 3% performed in the average range (Total Index score = 90-110). Across specific index scores, the percentage of participants performing in the impaired range varied: (1) 72.7% for Immediate Memory; (2) 47.1% for Visuospatial/Constructional; (3) 39.4% for Language; (4) 63.6% for Attention; and (5) 42.4% for Delayed Memory.
We first examined whether participant characteristics would influence RBANS Total score. First, age in years and years in the US were not significantly associated with RBANS Total score (r = .09-.24, p = .17-.63), but years of education were Similarly, an independent samples t-test indicated that RBANS Total score does not differ between participants who had legal incentive to feign cognitive impairments (M = 62.26, SD = 14.06), including those with PC §1370 and 5008 "Murphy" Conservatorship commitment types, and participants who had no legal incentive to feign cognitive impairments (M = 62.08, SD = 8.79), t(29) = 0.04, p = .97.
Specific Risk Factors
We first examined the influence of specific neurological risk factors on RBANS Total score (see Table 5 for a summary of t-test results). We found that RBANS Total score is not significantly influence by (1) history of head injury, (2) history of losing consciousness after a head injury, (3) history of being hospitalized after a head injury, and (4) history of seizures (p = .26-.69). Notably, we could not examine the influence of seizure history on RBANS performance because none of the participants endorsed having a history of seizure.
We next examined the influence of medical risk factors on RBANS Total score (see Table 6 for a summary of t-test results). Our results indicated that RBANS Totals score is not significantly influenced by (1) metabolic syndrome, (2) history of cerebrovascular disease, and (3) history of diabetes (p = .40-.82). Importantly, we could not examine the influence of history of cerebrovascular accident on RBANS performance due to there being only one participant endorsing having a history of cerebrovascular accident.
We then examined the influence of educational risk factors on RBANS Total score (see Table 7 for a summary of t-test results). Independent samples t-test revealed that RBANS Total score was not significantly influenced by a history of grade repetition (p = .89). In contrast, RBANS Total score was significantly lower among participants having less than 6 years of education (M = 58.20, SD = 10.76) compared to participants having more than 6 years of education (M = 66.92, SD = 12.17), t(31) = −2.16, p = .04, d = −.18. Notably, although we initially planned on examining whether RBANS performance would differ between those having less than 12 years of education compared to those having more than 12 years of education, this analysis could not be conducted because only one participant endorsed having more than 12 years of education. Because the average participant in the sample had around 6 years of education, we re-ran the analyses using revised classifications. Finally, we could not examine whether learning disability would influence RBANS Total score because only one participant endorsed having a learning disability.
General Risk Factors
We examined whether endorsement of any risk factors would influence RBANS Total score (see Table 8 ). Using independent samples t-test, we found that RBANS Total score is not significantly influenced by (1) medical risk factors, (2) neurological risk factors, and (3) educational risk factors (p = .12-.76, t = −1.61 to 0.32, Cohen's d = −.58 to .11).
We next examined whether total number of risk factors would influence RBANS Total score. Correlational analyses revealed that RBANS Total score was not significantly influenced by (1) the number of neurological risk factors and (2) the number of medical risk factors (r = .05-.12, p = .52-.80). However, the association of the number of educational risk factors with RBANS Total score fell short of significance (r = -.32, p = .07). Finally, the total number of risk factors (i.e., medical, neurological, and educational combined) was not significantly associated with RBANS Total score (r = -.13, p = .94).
Discussion
The present study is an exploratory investigation of how Spanish speaking forensic psychiatric inpatients perform on the Spanish version of the RBANS. This study is unique in that it utilizes the RBANS Spanish protocol along with the language corrections provided by the updated RBANS Manual (Randolph, 2012) . The primary goals of the present study were to ascertain the typical performance of Spanish speaking psychiatric inpatients on the RBANS and determine whether demographic, neuropsychological, or medical risk factors were useful in identifying inpatients with neuropsychological impairments on the RBANS.
Overall RBANS Performance
The current exploratory study revealed that, in our sample of monolingual Spanish speakers, the average Total Index score on the RBANS was 61.64. This is consistent with previous research demonstrating that psychiatric patients performed well below the mean when compared to healthy individuals (Bailie et al., 2012; Iverson et al., 2009; Martell, 1992) . Importantly, the average total index score for our sample is 12.95 points lower than reported in a previous study with English speakers in the same setting as the current study (Bailie et al., 2012) ; in this way, our sample of Spanish speaking patients achieved average scores that were almost one standard deviation lower than English speakers in the same setting. In addition, when compared to English speakers in the study by Bailie and colleagues (2012) , all other RBANS indices had lower mean scores for Spanish speakers: Visuospatial/Constructional index by 8.79 points, Attention by 8.93 points, Delayed Memory by 10.82 points, Immediate Memory by 14.17 points, and Language by 13.97 points.
Overall, RBANS performance for monolingual Spanish speaking forensic inpatients is considerably lower compared to English speaking forensic inpatients and the general population. Such general attenuation is crucial to note when working with this population given that neuropsychological tests tend to overestimate cognitive impairment in Spanish speaking individuals (Mindt et al., 2010) . Despite corrections for language, Spanish-speaking individuals in our study tended to perform lower on the RBANS than their English counterparts. The manual asserts that the Spanish version of the RBANS will yield expected results for Spanish-speaking U.S. residents after raw scores have been adjusted; however, our findings indicated that lower scores should be expected in our sample of monolingual Spanish speaking inpatients when compared to their English speaking peers.
Importantly, most Spanish speaking forensic inpatients in our sample have been diagnosed with a SSD. In this way, poorer RBANS performance among Spanish speaking forensic inpatients could be partially due to pervasive cognitive deficits that are observed in many patients with SSDs. Indeed, many studies have established that individuals with SSDs perform poorly across numerous cognitive domains compared to healthy individuals (see Bora, Yücel, & Pantelis, 2009; Heinrichs & Zakzanis, 1998; Keefe et al., 2006; Keefe & Fenton, 2007 , Mesholam-Galey, Giuliano, Faraone, Goff, & Sedman, 2009 ). Furthermore, a recent meta-analysis demonstrated that SSD is characterized by generalized impairments across numerous cognitive domains-including memory, attention, language, executive functioning, processing speed, and intelligence (Fioravanti, Bianchi, & Cinti, 2012) . Finally, forensic SSD inpatients are more likely to have grater psychiatric symptom severity, which could contribute to more pervasive cognitive impairments (see Ammari et al., 2014; Calev et al., 1983; Keefe et al., 2006; Reichenberg, 2010) .
Demographic and Risk Factors
When examining the effects of personal demographic factors in our sample, no significant associations were found between performance on the RBANS Total score and age of the participant. Similarly, gender, the number of years that a participant lived in the United States, country of birth, growing up in a rural versus urban setting, history of substance use, occupation type, or legal status were not significantly correlated with RBANS Total Index score. Importantly, there were no significant differences in RBANS Total Index scores between individuals were considered to have legal incentive to feign cognitive impairments (i.e., PC § 1370 and 5008 "Murphy Conservatorship") and individuals who had no legal incentive to feign cognitive incentives (PC § 1026 and PC §2972) were compared. These findings suggest that the Spanish RBANS can be useful for assessing inpatients who have incentive to feign, but who are otherwise providing adequate effort during the evaluation. In fact, when looking at personal demographic factors, only education was found to be associated with RBANS Total Index performance; as a group, more education was related to a higher score on the RBANS Total Index. The results of an abbreviated semi structured neuropsychological interview revealed that the majority of our sample endorsed at least one educational risk factor (i.e., repeating a grade, having a learning disability, or having less than 6 years of education). In fact, a significant portion of the sample endorsed having less than 6 years of education or having repeated a grade (72.80%). While the amount of risk factors the participants endorsed was not associated with RBANS Total score, the association approached significance. Future studies with a larger sample size are encouraged to revisit this issue.
The average participant in our study had approximately 6 years of education. We found that as participants with less than 6 years of education performed significantly worse on the RBANS Total score when compared to participants who had more than 6 years of education. In addition to being consistent with prior research (Bailie et al., 2012; Beatty, Mold, & Gontkovsky, 2003) , this finding suggests that lower RBANS scores in this population are likely due to level of education. However, because we have no comparison group, this could not be examined in the present study. Furthermore, there were no differences between subjects who repeated grades versus those that did not repeat grades; of note, this may be in part due to the limited amount of educational attainment of the sample as a whole. In other words, because the average grade achieved in this population is the 6th grade, there was not much time for many of the participants to repeat many grades; in contrast, the average 11th grade attainment of English speaking forensic inpatients allowed for more grade repetitions (Bailie et al., 2012) . Interestingly, only one participant endorsed having a learning disability, which surprising given the positive association between mental health disorders and learning disabilities (Sanderson, Best, Doody, Owens, & Johnstone, 1999; Smiley, 2005) . While the low prevalence of learning disabilities in our sample could be related to being generally underpowered, such low prevalence may reflect a general lack of testing and awareness about learning disabilities outside of the United States. Therefore, when neuropsychologists perform neuropsychological assessments with individuals who were educated outside of the United States, they should be mindful that a patient who does not endorse a learning disability may not have been properly identified in his or her country of origin.
Approximately half of our sample endorsed at least one neuropsychological risk factor (i.e., head injury with or without loss of consciousness, hospitalization following a head injury, and history of seizures). None of the neuropsychological risk factors were found to be associated with RBANS Total score. Additionally, the number of neuropsychological risk factors endorsed was also not associated with the RBANS Total score. While this finding is surprising given that past research has reliably found cognitive changes related to traumatic brain injury (McKay et al., 2007; McKay, Wertheimer, Fichtenberg, & Casey, 2008; Pachet, 2007; Randolph, 2012) , these results are not unique when looking at psychiatric inpatients. In fact, a prior study that looked at the relationship between neuropsychological risk factors and RBANS test performance among English speaking forensically committed psychiatric inpatients and the authors similarly found no correlation between RBANS performance and history of head trauma, with or without loss of consciousness or subsequent hospitalizations (Bailie et al., 2012) . As Bailie and colleagues (2012) point out, the affect of mental illness may attenuate the affect of other neuropsychological risk factors on cognitive testing. For example, a mental illness such as Schizophrenia may overshadow the effects of a head injury in terms of performance on the RBANS, particularly when that head injury is mild in severity. Future research could look at the relationship between head injury and mental illness in terms of neuropsychological functioning.
Approximately 38% of our sample endorsed at least one medical risk factor (i.e., metabolic syndrome, cerebrovascular accident, cardiovascular disease, and diabetes). Surprisingly, none of the medical risk factors were found to be associated with the RBANS Total score. Also unexpected, having endorsed an increased number of neuropsychological risk factors was also not associated with the RBANS Total score. This may be due to the low number of subjects available for this study. However, this may also be due to the fact that participants in this study were hospitalized, and as a result of the setting, their medical risk factors were typically well controlled at the time of the evaluation. Alternatively, it may be that for our population of subjects, the psychiatric morbidity outweighed other factors, including medical risk factors. Thus, our subjects may have had a psychiatric condition while at the same time being physically healthy.
Importantly, 88.2% of our sample endorsed having at least one risk factor for cognitive impairment. However, the total number of risk factors was not associated with the RBANS Total score. Furthermore, the RBANS Total score did not differ between participants who endorsed educational, neurological, or medical risk factors versus those that did not. One possible explanation is that the level of pathology is so severe for this population that the RBANS scores are depressed below the level at which having other risk factors even matter; in this case, restriction of range might obscure potential effect of risk factors on RBANS Total score performance. Additionally, it may be that since this study relied on self-report, we did not gain an accurate picture of past history for these patients. Future research may want to explore these issues in more detail.
Limitations
This study has several limitations that should be addressed. Notably, this study had a small sample size and was subsequently underpowered, which may have limited the amount of significant associations found for this population. Relatedly, some analyses could not be run (e.g., influence of learning disability on RBANS performance) and/or should be cautiously interpreted (e.g., influence of gender on RBANS performance) due to under-representations of some groups of participants, which are related to the small sample size. Future studies should utilize a larger sample of participants when examining the performance of Spanish speaking forensic inpatients on the RBANS; notably, those studies can elucidate the robustness of the present study's findings. Furthermore, our sample had a fairly restricted range of education, with the average range of education attainment being 6 years. Future studies should look at performance of English and Spanish-speaking forensic inpatients with comparable levels of education. Additionally, we relied upon a sample of convenience, as well as archival data collected for clinical purposes. Thus, our data may not be representative of the population of interest; subsequently, the generalizability of our results to other Spanish speaking populations is not clear. Future studies should focus on how other subgroups of Spanish speakers perform on the Spanish version of the RBANS. Finally, we examined whether total number of specific and general risk factors would correlate with RBANS Total score. However, this approach may be inappropriate, especially considering that additional risk factors may ultimately be on an ordinal scale and should not be compounded.
Conclusions
Despite these aforementioned limitations, this study was unique and expanded on previous research in the following ways: (1) this study examined RBANS performance among monolingual Spanish speaking forensic inpatients; and (2) this study utilized the official Spanish protocol provided by the test authors along with the Spanish language corrections provided by the manual (Randolph, 2012) . Despite using corrected raw scores, we found that Spanish speaking forensic psychiatric inpatient participants performed lower than expected, especially in comparison to English speaking forensic psychiatric inpatients from the same setting (Bailie et al., 2012) . Additionally, although most risk factors did not significantly influence RBANS Total score performance, we found that individuals who had less than a 6th grade education level performed worse on RBANS Total score than individuals that had more than a 6th grade education. Collectively, these findings can serve as the first step in helping to define "normative" cognition in regards to Spanish speaking forensic psychiatric patients and can guide future researchers in their attempts to evaluate the utility of the RBANS in other clinical Spanish speaking groups. Importantly, having a better appreciation of "normative" cognitive performance for Spanish speaking psychiatric patients may reduce the likelihood of over-pathologizing performance and increase the likelihood that treatment will be better tailored to the patient's cognitive ability, particularly in regards to meeting forensic treatment goals.
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